TINA NITSOS: Open Payments
NPI 1891162764 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 41 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $182 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $321 |
| Braeburn Inc. | 14 | $194 |
| Gilead Sciences, Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Indivior Inc. | 3 | $46 |
| Orexo US, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $17 |
Products named: MAVYRET, BRIXADI, CAPLYTA, SUBLOCADE, Zubsolv, Auvelity, REXULTI, Dyanavel XR.
Industry payments across IN — which companies pay providers there.
